Cell Impact AB (SE:CI)

:CI

Cell Impact AB

RESEARCH TOOLSreports

Want to see SE:CI full AI Analyst Report?

Cell Impact AB (CI) Price & Analysis

2 Followers

CI Stock Chart & Stats

kr0.26

>-kr0.01(-4.05%)

At close: Mar 06 4:00 PM EST

kr0.26

>-kr0.01(-4.05%)

Day’s Range― - ―

52-Week Rangekr0.09 - kr0.74

Previous CloseN/A

Volume1.37M

Average Volume (3M)4.50M

Market Cap

kr62.46M

Enterprise Valuekr50.89M

Total Cash (Recent Filing)kr3.95M

Total Debt (Recent Filing)kr14.86M

Price to Earnings (P/E)―

Beta1.13

Next Earnings

Aug 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.41

Shares Outstanding487,225,200

10 Day Avg. Volume6,494,872

30 Day Avg. Volume4,501,845

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.27

Price to Sales (P/S)5.83

P/FCF Ratio-0.69

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.48

Revenue Forecast (FY)kr40.00M

Bulls Say, Bears Say

Bulls Say

Proprietary Forming TechnologyCell Impact’s proprietary high-velocity forming technology is a durable competitive asset that enables specialized flow plate production and tooling services. This capability can create barriers to entry, support higher engineering margins on industrialization work and foster longer-term customer relationships as clients industrialize fuel cell stack production.

Aligned With Hydrogen Value ChainThe company’s focus on flow plates for fuel cells and electrolyzers ties revenue to multi-year structural demand from decarbonization and hydrogen deployment. Being positioned in a core component segment offers durable market opportunity as OEMs scale stacks and electrolysis systems, supporting repeatable production and service revenue streams over several quarters to years.

Low Financial LeverageA low debt-to-equity ratio (~0.12) provides financial flexibility while the company works to stabilize operations. Lower leverage reduces short-term solvency risk and preserves capacity to raise incremental capital or invest in production scale-ups, offering a structural cushion as the business executes commercialization and industrialization plans.

Bears Say

Deep Negative MarginsSustained deeply negative margins across gross, operating and net lines indicate the business is structurally loss-making at current scale. Persistent margin deficits point to pricing pressure, high unit costs or under-absorbed fixed costs, impairing the firm’s ability to generate profits as volumes ramp and threatening long-term viability without structural improvement.

Material Cash BurnLarge negative operating and free cash flows show the company is consuming capital to run operations and industrialize production. Ongoing cash burn necessitates external financing or equity raises, which can dilute investors and constrain the firm’s ability to invest in scale, meet contract milestones, or absorb cyclical shocks over the medium term.

Sharp Recent Revenue WeaknessA very steep reported revenue decline suggests the company lacks the sales scale necessary to cover fixed costs and achieve economies of production. Reduced top-line momentum undermines margin recovery, delays industrialization milestones and makes converting technological advantages into profitable, repeatable volume business more difficult over coming quarters.

CI FAQ

What was Cell Impact AB’s price range in the past 12 months?

Cell Impact AB lowest stock price was kr0.09 and its highest was kr0.74 in the past 12 months.

What is Cell Impact AB’s market cap?

Cell Impact AB’s market cap is kr62.46M.

When is Cell Impact AB’s upcoming earnings report date?

Cell Impact AB’s upcoming earnings report date is Aug 21, 2026 which is in 70 days.

How were Cell Impact AB’s earnings last quarter?

Cell Impact AB released its earnings results on May 13, 2026. The company reported -kr0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.053.

Is Cell Impact AB overvalued?

According to Wall Street analysts Cell Impact AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cell Impact AB pay dividends?

Cell Impact AB does not currently pay dividends.

What is Cell Impact AB’s EPS estimate?

Cell Impact AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cell Impact AB have?

Cell Impact AB has 487,225,200 shares outstanding.

What happened to Cell Impact AB’s price movement after its last earnings report?

Cell Impact AB reported an EPS of -kr0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -25.112%.

Which hedge fund is a major shareholder of Cell Impact AB?

Currently, no hedge funds are holding shares in SE:CI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cell Impact AB

Cell Impact AB (publ) is a Swedish firm that specializes in the global production and distribution of bipolar flow plates, which are crucial components for hydrogen fuel cells. The company's products include plates designed with meticulously precise flow patterns, primarily serving manufacturers within the hydrogen fuel cell industry. Founded in 1999, its headquarters are located in Karlskoga, Sweden.